Northwest Biotherapeutics (OTCMKTS:NWBO – Get Rating) is one of 992 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Northwest Biotherapeutics to related companies based on the strength of its risk, earnings, valuation, profitability, dividends, analyst recommendations and institutional ownership. Earnings and Valuation This table compares […]
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Rating) was the recipient of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 138,200 shares, a decline of 30.1% from the March 15th total of 197,800 shares. Currently, 0.4% of the company’s shares are short sold. Based […]
HC Wainwright reaffirmed their buy rating on shares of SAB Biotherapeutics (NASDAQ:SABS – Get Rating) in a research note released on Monday morning, Benzinga reports. The firm currently has a $4.00 target price on the stock. SAB Biotherapeutics Price Performance SAB Biotherapeutics stock opened at $0.44 on Monday. The stock’s 50 day moving average price […]
Should You Buy or Sell Northwest Biotherapeutics Stock? Get The Latest NWBO Stock Forecast, Price Target, Earnings Estimates, and Headlines at MarketBeat.